The record → All 128 providers → Maximus
Provider Dossier · maximustribe.com · Last verified 30 October 2026
Is Maximus legit?
Quick answerLast verified · GLP-1 Dossier Editorial Desk
Our enforcement sweep matched 1 primary-sourced regulatory or legal action on file involving Maximus (maximustribe.com), each linked to the original document below.
Published prices start at $99.99/mo, with medication included.
It offers both compounded and FDA-approved GLP-1 options.
Disclosure: Unmonetized direct link (Maximus has no commercial relationship with this site).
Yes, Maximus (maximustribe.com) is a real, operating US telehealth company that ships prescriptions, not a counterfeit card-skimming site. However, our enforcement sweep matched 1 primary-sourced regulatory or legal action on file involving the company, each linked to the original government or court document below.
On the clinical side, Maximus offers both compounded and FDA-approved GLP-1 options at sharply different price tiers, and its published plan starts at $99.99/mo (medication included).
Comparing Maximus against compounded and branded providers with 0 actions on file
Maximus has 1 regulatory or legal action documented below. For readers comparing transparent options in the same supply category before entering payment details, these providers have 0 actions on file and published monthly pricing:
- Website & Terms inspected
- maximustribe.com (Direct checkout & Terms of Service verified)
- Last price & terms read
- 16 November 2026 (Medication included in quoted monthly rate · Flat rate across all doses)
- 503A / 503B pharmacy disclosure
- No partner compounding pharmacy named upfront before intake
- Public registries searched
- FDA CDER Warning Letters (2024–2026), Federal District Court Dockets (PACER / CourtListener), FTC Enforcement Actions, NAD Case Reports → 1 primary document linked below
- Researcher field note
- Maximus (maximustribe.com/weight-loss; operated by Maximus Health, Inc. d/b/a Maximus) is a men’s and women’s metabolic, hormone optimization (testosterone and enclomiphene protocols), hair loss (Warrior Hair Loss protocol), blood flow, and GLP-1 weight-loss telehealth platform serving over 50,000 clients. Its Weight Loss Protocol offers flat-dose base-form compounded tirzepatide ($99.99/month on a 12-month plan up to $199.99/month on a 2-month plan, shipped every 2 months with no membership fee) and compounded semaglutide ($116 per 28-day supply), alongside FDA-approved brand-name Foundayo tablets ($199.99/mo), Wegovy tablets ($249.99/mo), Wegovy pens ($349.99/mo), Ozempic ($349.99/mo), Zepbound ($449.99/mo), and Mounjaro ($1,249.99/mo), with HSA/FSA accepted and full refunds (less the doctor consultation fee) if not clinically approved. Following the June 2026 FDA warning letter (MARCS-CMS 730095) concerning website phrasing on compounded GLP-1 pages, Maximus updated maximustribe.com/weight-loss to prominently state in capital letters that compounded medications are not FDA-approved for safety, efficacy, or quality, explicitly specify the use of base-form tirzepatide rather than salt forms, and separate compounded pharmacy preparations from FDA-approved Novo Nordisk and Eli Lilly products in a side-by-side regulatory table.
What it actually supplies
Supplies both compounded medication and FDA-approved branded drugs, usually at very different prices. Check which one a quoted price refers to.
Named on its own site (maximustribe.com): Semaglutide, Tirzepatide, Foundayo Tablets, Wegovy Tablets, Wegovy Pens, Ozempic, Zepbound, Mounjaro.
What regulators and courts have said
Every entry below links to its original document and identifies the source type. We publish what the official record states and nothing beyond it; a regulatory letter or lawsuit involving a company is not proof that an individual patient was harmed.
June 2026
FDA warning letter to Maximus Health, Inc. dba Maximus alleging its website made false or misleading claims about compounded semaglutide and tirzepatide, including "Proven to lose weight effectively" and references to "FDA approved pharmacies" that represented the compounded products as FDA-approved or evaluated for safety and effectiveness.
Corporate entity, pricing & cancellation terms
Maximus (maximustribe.com/weight-loss; operated by Maximus Health, Inc. d/b/a Maximus) is a men’s and women’s metabolic, hormone optimization (testosterone and enclomiphene protocols), hair loss (Warrior Hair Loss protocol), blood flow, and GLP-1 weight-loss telehealth platform serving over 50,000 clients. Its Weight Loss Protocol offers flat-dose base-form compounded tirzepatide ($99.99/month on a 12-month plan up to $199.99/month on a 2-month plan, shipped every 2 months with no membership fee) and compounded semaglutide ($116 per 28-day supply), alongside FDA-approved brand-name Foundayo tablets ($199.99/mo), Wegovy tablets ($249.99/mo), Wegovy pens ($349.99/mo), Ozempic ($349.99/mo), Zepbound ($449.99/mo), and Mounjaro ($1,249.99/mo), with HSA/FSA accepted and full refunds (less the doctor consultation fee) if not clinically approved. Following the June 2026 FDA warning letter (MARCS-CMS 730095) concerning website phrasing on compounded GLP-1 pages, Maximus updated maximustribe.com/weight-loss to prominently state in capital letters that compounded medications are not FDA-approved for safety, efficacy, or quality, explicitly specify the use of base-form tirzepatide rather than salt forms, and separate compounded pharmacy preparations from FDA-approved Novo Nordisk and Eli Lilly products in a side-by-side regulatory table.
Go direct
The button below is a plain direct link to Maximus and earns us nothing. Maximus has no commercial arrangement with this desk and is documented under the exact same verification rules as companies that do pay.
Visit Maximus (maximustribe.com) →Lower advertised starting prices
Providers advertising a lower monthly entry figure. Check each dossier before comparing two numbers: the headline price alone does not tell you whether medication is included.
If you prefer FDA-approved medication only
These clinics prescribe FDA-approved brand-name drugs only and currently have 0 regulatory actions on file here.
Side-by-side records
Compared with the alternatives
Direct dossier comparisons for the providers patients most frequently weigh against Maximus.
Long-form provider files
Full price tables, terms and records
Every plan length, the refund and cancellation terms, named pharmacies, review-site links and each regulatory action with its primary document. These 6 providers pay us a referral commission if you sign up through our links; ordered by lowest verified monthly price only.
| Provider file | Sema. /mo | Tirz. /mo | Actions on file | Links |
|---|---|---|---|---|
| Embody | $49 | $99 | None | Read the dossier →Embody site ↗ |
| Belle | $93 | $149 | 1 | Read the dossier →Belle site ↗ |
| PlexusDx | $99 | $129 | None | Read the dossier →PlexusDx site ↗ |
| MEDGm | $169 | $269 | None | Read the dossier →MEDGm site ↗ |
| DirectMeds | $249 | $399 | 1 | Read the dossier →DirectMeds site ↗ |
| GoodLife Health | $299 membership | + brand-name drug | None | Read the dossier →GoodLife Health site ↗ |
- Embodyfrom $49/moSema. $49 · Tirz. $99None on file
- Bellefrom $93/moSema. $93 · Tirz. $1491 on file
- PlexusDxfrom $99/moSema. $99 · Tirz. $129None on file
- MEDGmfrom $169/moSema. $169 · Tirz. $269None on file
- DirectMedsfrom $249/moSema. $249 · Tirz. $3991 on file
- GoodLife Healthfrom $299/mo + drugMembership; brand-name drug billed separatelyNone on file
Each row has two links: “Read the dossier” opens our file on that provider, and the “site ↗” button opens the provider’s own site in a new tab. Nothing else in the row is a link. Where a provider runs an affiliate programme with us, its site button is a referral link and we may earn a commission at no cost to you. It never changes the order or what is on file.
Reference notes
Maximus: key questions answered
- Is Maximus (maximustribe.com) legit or a scam? What does the public record show?
- Yes. Maximus (maximustribe.com) is an active, operating US weight-loss telehealth company. It offers both compounded GLP-1 formulations and FDA-approved brand-name drugs at distinct price points. Our regulatory sweep matched 1 primary-sourced regulatory or legal action on file: FDA warning letter to Maximus Health, Inc. dba Maximus alleging its website made false or misleading claims about compounded semaglutide and tirzepatide, including "Proven to lose weight effectively" and references to "FDA approved pharmacies" that represented the compounded products as FDA-approved or evaluated for safety and effectiveness.
- Does Maximus sell compounded or FDA-approved weight loss medication?
- Compounded and branded. Supplies both compounded medication and FDA-approved branded drugs, usually at very different prices. Check which one a quoted price refers to. Specifically named on maximustribe.com: Semaglutide, Tirzepatide, Foundayo Tablets, Wegovy Tablets, Wegovy Pens, Ozempic, Zepbound, Mounjaro.
- What are Maximus weight loss pricing, hidden fees, and cancellation terms?
- Maximus (maximustribe.com) publishes weight-loss plans starting at $99.99 per month, with medication included in that monthly figure. Contract and billing terms: No separate membership fee; flat-dose base-form compounded tirzepatide is $99.99/mo on a 12-month plan ($119.99/mo on 6-mo, $149.99/mo on 4-mo, or $199.99/mo on 2-mo, billed upfront and shipped in 2-month batches), compounded semaglutide starts at $116 per 28-day supply, and FDA-approved branded options start at $199.99/mo (Foundayo tablets) to $1,249.99/mo (Mounjaro). Maximus (maximustribe.com/weight-loss; operated by Maximus Health, Inc. d/b/a Maximus) is a men’s and women’s metabolic, hormone optimization (testosterone and enclomiphene protocols), hair loss (Warrior Hair Loss protocol), blood flow, and GLP-1 weight-loss telehealth platform serving over 50,000 clients. Its Weight Loss Protocol offers flat-dose base-form compounded tirzepatide ($99.99/month on a 12-month plan up to $199.99/month on a 2-month plan, shipped every 2 months with no membership fee) and compounded semaglutide ($116 per 28-day supply), alongside FDA-approved brand-name Foundayo tablets ($199.99/mo), Wegovy tablets ($249.99/mo), Wegovy pens ($349.99/mo), Ozempic ($349.99/mo), Zepbound ($449.99/mo), and Mounjaro ($1,249.99/mo), with HSA/FSA accepted and full refunds (less the doctor consultation fee) if not clinically approved. Following the June 2026 FDA warning letter (MARCS-CMS 730095) concerning website phrasing on compounded GLP-1 pages, Maximus updated maximustribe.com/weight-loss to prominently state in capital letters that compounded medications are not FDA-approved for safety, efficacy, or quality, explicitly specify the use of base-form tirzepatide rather than salt forms, and separate compounded pharmacy preparations from FDA-approved Novo Nordisk and Eli Lilly products in a side-by-side regulatory table.
- What compounding or fulfillment pharmacy does Maximus use?
- Maximus (maximustribe.com) states that compounded GLP-1 prescriptions are fulfilled through state-licensed 503A or 503B compounding pharmacies, without listing specific partner pharmacy names on its public pre-checkout pages. Patients can verify the exact compounding pharmacy, address, and state board license number printed on the prescription vial label upon delivery.
- Are there FDA warning letters, lawsuits, or regulatory complaints against Maximus?
- Yes. We hold 1 primary-sourced regulatory or legal action on record involving Maximus (maximustribe.com): FDA warning letter to Maximus Health, Inc. dba Maximus alleging its website made false or misleading claims about compounded semaglutide and tirzepatide, including "Proven to lose weight effectively" and references to "FDA approved pharmacies" that represented the compounded products as FDA-approved or evaluated for safety and effectiveness. Every entry links directly to the primary FDA, NAD, or court document on this page.
- How do Maximus oral GLP-1 tablets or sublingual drops compare with FDA-approved oral semaglutide?
- Maximus (maximustribe.com) lists (Semaglutide, Tirzepatide, Foundayo Tablets, Wegovy Tablets, Wegovy Pens, Ozempic, Zepbound, Mounjaro). Where Maximus dispenses a compounded oral GLP-1 tablet, sublingual drop, or dissolving troche, that formulation is prepared by a compounding pharmacy and is not an FDA-approved product; where it prescribes an FDA-approved oral GLP-1 (such as Rybelsus or the Wegovy pill), the medication is manufactured in an FDA-inspected facility with FDA-reviewed bioavailability and clinical efficacy data.